These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 22898255

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Synthesis, biological evaluation and docking studies of new pyrrolo[2,3-d] pyrimidine derivatives as Src family-selective tyrosine kinase inhibitors.
    Dincer S, Cetin KT, Onay-Besikci A, Ölgen S.
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1080-7. PubMed ID: 22957720
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Kinetics of inhibition of firefly luciferase by oxyluciferin and dehydroluciferyl-adenylate.
    Ribeiro C, Esteves da Silva JC.
    Photochem Photobiol Sci; 2008 Sep; 7(9):1085-90. PubMed ID: 18754056
    [Abstract] [Full Text] [Related]

  • 25. Identification of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration.
    Caldwell JJ, Davies TG, Donald A, McHardy T, Rowlands MG, Aherne GW, Hunter LK, Taylor K, Ruddle R, Raynaud FI, Verdonk M, Workman P, Garrett MD, Collins I.
    J Med Chem; 2008 Apr 10; 51(7):2147-57. PubMed ID: 18345609
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. 4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase.
    Traxler PM, Furet P, Mett H, Buchdunger E, Meyer T, Lydon N.
    J Med Chem; 1996 Jun 07; 39(12):2285-92. PubMed ID: 8691423
    [Abstract] [Full Text] [Related]

  • 32. Convergent synthesis and cruzain inhibitory activity of novel 2-(N'-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines.
    Zanatta N, Amaral SS, Dos Santos JM, de Mello DL, Fernandes Lda S, Bonacorso HG, Martins MA, Andricopulo AD, Borchhardt DM.
    Bioorg Med Chem; 2008 Dec 15; 16(24):10236-43. PubMed ID: 18996017
    [Abstract] [Full Text] [Related]

  • 33. Synthesis and structure-activity relationship of 4-substituted 2-(2-acetyloxyethyl)-8-(morpholine-4-sulfonyl)pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors.
    Kravchenko DV, Kuzovkova YA, Kysil VM, Tkachenko SE, Maliarchouk S, Okun IM, Balakin KV, Ivachtchenko AV.
    J Med Chem; 2005 Jun 02; 48(11):3680-3. PubMed ID: 15916416
    [Abstract] [Full Text] [Related]

  • 34. Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck I.
    Arnold LD, Calderwood DJ, Dixon RW, Johnston DN, Kamens JS, Munschauer R, Rafferty P, Ratnofsky SE.
    Bioorg Med Chem Lett; 2000 Oct 02; 10(19):2167-70. PubMed ID: 11012021
    [Abstract] [Full Text] [Related]

  • 35. Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-Raf(V600E) kinase with favorable physicochemical and pharmacokinetic properties.
    Ren L, Laird ER, Buckmelter AJ, Dinkel V, Gloor SL, Grina J, Newhouse B, Rasor K, Hastings G, Gradl SN, Rudolph J.
    Bioorg Med Chem Lett; 2012 Jan 15; 22(2):1165-8. PubMed ID: 22196124
    [Abstract] [Full Text] [Related]

  • 36. A CoMSIA study on the adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues.
    Caballero J, Fernández M, González-Nilo FD.
    Bioorg Med Chem; 2008 May 01; 16(9):5103-8. PubMed ID: 18359230
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity.
    Chamberlain SD, Redman AM, Wilson JW, Deanda F, Shotwell JB, Gerding R, Lei H, Yang B, Stevens KL, Hassell AM, Shewchuk LM, Leesnitzer MA, Smith JL, Sabbatini P, Atkins C, Groy A, Rowand JL, Kumar R, Mook RA, Moorthy G, Patnaik S.
    Bioorg Med Chem Lett; 2009 Jan 15; 19(2):360-4. PubMed ID: 19071018
    [Abstract] [Full Text] [Related]

  • 39. Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives and evaluation of their activities against human colon cancer cell lines.
    Tangeda SJ, Garlapati A.
    Eur J Med Chem; 2010 Apr 15; 45(4):1453-8. PubMed ID: 20163895
    [Abstract] [Full Text] [Related]

  • 40. Pyrrolo[2,3-d]pyrimidine thymidylate synthase inhibitors: design and synthesis of one-carbon bridge derivatives.
    Aso K, Imai Y, Yukishige K, Ootsu K, Akimoto H.
    Chem Pharm Bull (Tokyo); 2001 Oct 15; 49(10):1280-7. PubMed ID: 11605654
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.